Venetia Zachariou, PhD
img_Venetia Zachariou
Research Topics
Addiction, Behavioral Health, Brain, Depression, Epigenetics, Gene Therapy, Knockout Mice, Membrane Proteins/Channels, Molecular Biology, Neurobiology, Neuroscience, Obesity, Opioid/Cannabinoid Receptors, Pain, Pharmacology, Protein Complexes, Signal Transduction, Spinal Cord, Synaptic Plasticity, Systems Neuroscience, Tolerance, Transcription Factors, Transgenic Mice
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT), Neuroscience [NEU]
Research Areas:
  • The function of signal transduction complexes in the striatum in drug addiction
  • Regulation of G protein signaling in chronic stress and antidepressant treatment
  • Novel intracellular targets for the treatment of chronic pain
  • Epigenetic adaptations in neuropathic and inflammatory pain
  • The role of the brain reward center in chronic pain and its treatment

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Zachariou is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.